CAR-T treatment of children with recurrent B-cell acute lymphoblastic leukemia gets complete remission

On May 27, 2020, CAR-T treatment was re-examined for 9 and a half months, and the bone marrow was in a continuous and complete state of remissionthis year's Children's Day, Hebei children Xiaoxia received a gift from uncles and aunts of Beijing Century Temple Hospital, he was very happyXiao Xia is an 8-year-old child with acute lymphoblastic leukemia, August 5, 2019, Xiao Xia received autologous CD19-CAR-T cell immunotherapy, May 27, 2020, CAR-T treatment has been 9 and a half months of Xiaoxia re-reviewed the bone marrow in a continuous complete state of remission, for the hospital to continue to promote CAR-T clinical research project to bring a good start3 years ago, lively and lovely Xiao Xia was diagnosed with "B-cell acute lymphoblastic leukemia", three years has been fighting the disease, Xiao Xia suffered from healthy peers can not imagine pain, but the disease is still relapsingAnxious parents rushed to seek medical attention, to Beijing Century Tan Hospital is carrying out CAR-T treatment recurrence / refractive acute lymphoblastic leukemia clinical research, after careful understanding, the child's parents decided to let children to car-T treatmentThe CAR-T treatment team at Century Temple Hospital conducted a comprehensive assessment of the child's condition, and on August 5, 2019, Xiao Xia received immunotherapy for autologous CD19-CAR-T cellsAfter the infusion in January, the bone marrow puncture was reviewed, and the results indicated that the condition was completely remissionAfter regular follow-up visits to the hospital, did not receive other treatment, repeatedly review edilim continuous remission, organ function and other indicators are normalNow CAR-T treatment for 9 and a half months, the review is still in a completely remissionstated state, the blood can still detect CAR-T cell survivalthe eve of the "June 1" Children's Day, century-old hospital CAR-T treatment team will be children's day gifts sent to the small summer home, sincerely wish the children's day happy! CAR-T treatment team will continue to pay close attention to the progress of the child's disease, develop the best treatment plan, and wish the child a speedy recovery, return to school!this technology is a newly developed genetically engineered retrofit t-cell immunotherapy technology, CAR-T cells can specifically target tumor cells, with a strong ability to kill tumor cellsCAR-T therapy offers new hope for children with recurrent/difficult leukemiaSource:, Beijing Century Temple Hospital, affiliated with Capital Medical University